JPS63258850A - Production of l-cystine - Google Patents
Production of l-cystineInfo
- Publication number
- JPS63258850A JPS63258850A JP9190287A JP9190287A JPS63258850A JP S63258850 A JPS63258850 A JP S63258850A JP 9190287 A JP9190287 A JP 9190287A JP 9190287 A JP9190287 A JP 9190287A JP S63258850 A JPS63258850 A JP S63258850A
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- cystine
- reaction
- serine
- hydrogen sulfide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 title claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 57
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 37
- 229960003067 cystine Drugs 0.000 claims abstract description 36
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims abstract description 20
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 19
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims abstract description 15
- 108010075344 Tryptophan synthase Proteins 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- 230000001590 oxidative effect Effects 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- -1 alkali metal hydrosulfide Chemical class 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 229910052977 alkali metal sulfide Inorganic materials 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 abstract description 28
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 28
- 239000000243 solution Substances 0.000 abstract description 28
- 239000002994 raw material Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 abstract description 2
- 239000000490 cosmetic additive Substances 0.000 abstract description 2
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract description 2
- 239000003513 alkali Substances 0.000 abstract 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 239000013078 crystal Substances 0.000 description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000007664 blowing Methods 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 102000020018 Cystathionine gamma-Lyase Human genes 0.000 description 3
- 108010045283 Cystathionine gamma-lyase Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- VHPXSBIFWDAFMB-UHFFFAOYSA-N 2-amino-Delta(2)-thiazoline-4-carboxylic acid Chemical compound NC1=[NH+]C(C([O-])=O)CS1 VHPXSBIFWDAFMB-UHFFFAOYSA-N 0.000 description 1
- JTWUZULPZAALRN-UHFFFAOYSA-N 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde;phosphoric acid Chemical compound OP(O)(O)=O.CC1=NC=C(CO)C(C=O)=C1O JTWUZULPZAALRN-UHFFFAOYSA-N 0.000 description 1
- 101000889837 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) Protein CysO Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003295 alanine group Chemical class N[C@@H](C)C(=O)* 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010799 enzyme reaction rate Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-M hydrosulfide Chemical compound [SH-] RWSOTUBLDIXVET-UHFFFAOYSA-M 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052976 metal sulfide Chemical class 0.000 description 1
- IHYNKGRWCDKNEG-UHFFFAOYSA-N n-(4-bromophenyl)-2,6-dihydroxybenzamide Chemical compound OC1=CC=CC(O)=C1C(=O)NC1=CC=C(Br)C=C1 IHYNKGRWCDKNEG-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、酵素法にて!−シスチンを得る方法に関する
。[Detailed Description of the Invention] (Industrial Application Field) The present invention uses an enzyme method! - Concerning a method for obtaining cystine.
シスチンは還元をすることにより容易にシスティンへ変
換が可能であり、2−シスチン、2−システィンは医薬
あるいは医薬原料、食品添加物、化粧品添加物などとし
て利用されており、特に近年はコールドパーマ液の原料
などとしても需要が伸びているS元素含有のアミノ酸で
ある。Cystine can be easily converted to cysteine by reduction, and 2-cystine and 2-cystine are used as medicines or raw materials for medicines, food additives, cosmetic additives, etc., and especially in recent years, they have been used as cold perm liquids. It is an amino acid containing S element, which is in increasing demand as a raw material for.
(従来の技術及び発明が解決しようとする問題点)従来
!−システィンの製法としては、(1)天然物から抽出
する方法、(2)有機合成法、(3)発酵法、(4)酵
素法などが知られているが、天然物から抽出する方法に
ついては、原料の供給が不安定であり、且つ不要な他の
アミノ酸が混入する。また有機合成法においてはり、
L一体の分割を要する。更に発酵法は蓄積量が低いな
どの欠点があり、工業的に有利な製法とは言い難い。(Prior art and problems to be solved by the invention) Conventional! - Known methods for producing cysteine include (1) extraction from natural products, (2) organic synthesis, (3) fermentation, and (4) enzymatic methods. However, the supply of raw materials is unstable and other unnecessary amino acids are mixed in. In addition, in organic synthesis methods,
Requires division of L. Furthermore, the fermentation method has drawbacks such as a low accumulation amount, so it is difficult to say that it is an industrially advantageous production method.
酵素を用いて2−システィンを合成する酵素方法として
は、(1)システィン・シンターゼや、システィン・デ
スルフヒドラーゼを用いて!−セリンと硫化水素から合
成する方法、(2)システィン・デスルフヒドラーゼを
用いてβ−置換アラニンと金属硫化物などから合成する
方法、(3)2−アミノ−チアゾリン−4−カルボン酸
(ATC)から、ff1−ATC−ヒドラーゼ、ATC
−ラセマーゼ、S−カルバミル−l−システィン・ヒド
ラーゼを用いて合成する方法などが知られている。また
本出願人は、先に2−セリンと金属水硫化物などのスル
フヒドリル基を有する化合物とをトリプトファン・シン
ターゼの存在下反応させて得る方法を出願した(特願昭
60−84545号)。Enzymatic methods for synthesizing 2-cysteine using enzymes include (1) using cysteine synthase and cysteine desulfhydrase! - Synthesis from serine and hydrogen sulfide, (2) Synthesis from β-substituted alanine and metal sulfide using cysteine desulfhydrase, (3) 2-amino-thiazoline-4-carboxylic acid ( ATC), ff1-ATC-hydrolase, ATC
- Synthesis methods using racemase, S-carbamyl-l-cysteine hydrolase, etc. are known. The present applicant has previously applied for a method of reacting 2-serine with a compound having a sulfhydryl group such as a metal hydrosulfide in the presence of tryptophan synthase (Japanese Patent Application No. 84545/1982).
これらの発酵法を問わず、発酵法、合成法のいずれにお
いてもシスティン含有反応液よりシルティンの分離にお
いては、反応液の組成が複雑であることと、システィン
の水に対する溶解度が非常に大きいためシスティン含有
反応液より直接システィンとして単離・精製することは
極めて難しく、通常システィンを一旦強制的に酸化して
シスチンとして精製・単離を行い、必要により電解還元
などにより精システィンとして回収する方法が知られて
いる。Regardless of these fermentation methods, in both fermentation and synthesis methods, when it comes to separating cysteine from a cysteine-containing reaction solution, it is difficult to separate cysteine from a cysteine-containing reaction solution because the composition of the reaction solution is complex and cysteine has a very high solubility in water. It is extremely difficult to isolate and purify cystine directly from the reaction solution containing cysteine; the usual method is to forcibly oxidize cysteine, purify and isolate it as cysteine, and if necessary recover it as refined cysteine by electrolytic reduction. It is being
またシスティンからシスチンへの酸化方法も若干知られ
ており、例えば特公昭57−7634公報ではシスティ
ン発酵水溶液中のシスティンをpH5〜10の範囲に維
持して、空気酸化やH!0.などの過酸化物を用いた酸
化方法が記載されている。In addition, some methods for oxidizing cysteine to cystine are known. For example, in Japanese Patent Publication No. 7634/1983, cysteine in a cysteine fermentation aqueous solution is maintained at pH 5 to 10, and air oxidation or H! 0. Oxidation methods using peroxides such as
しかしながら該方法は、例えば!−セリンよりシスチン
を得る場合は、一旦酵素反応を終了してシスティンを製
造した後でないと適用できず、またntogや空気によ
る酸化方法は、システィン酸化反応条件制御に難があり
、酸化反応条件を厳しく制御しなければかなりの割合で
シスチン以外の分解物が生じるなど問題点があった。However, the method, for example! - When obtaining cystine from serine, it cannot be applied until after the enzymatic reaction has been completed and cysteine has been produced, and the oxidation method using ntog or air has difficulty controlling the cystine oxidation reaction conditions; If not strictly controlled, there were problems such as a considerable proportion of decomposition products other than cystine being produced.
また、l−セリンの酵素反応においては、用いるスルフ
ヒドリル基化合物としては、硫化水素(Hls )を直
接使用したほうが反応性が高いことが予想でき、また価
格も安いにもかかわらずH,Sガスは水に対する溶解度
がほとんどないため、通常はHzS源としては水硫化ソ
ーダなどの水可溶性塩が使用されていた。In addition, in the enzymatic reaction of l-serine, it can be expected that the direct use of hydrogen sulfide (Hls) as the sulfhydryl group compound will have higher reactivity, and although it is cheaper, H and S gases are Since it has little solubility in water, water-soluble salts such as sodium bisulfide have usually been used as HzS sources.
(問題点を解決するための手段)
本発明者らは、上記のような問題点を踏まえて、鋭意検
討の結果、本発明方法に達したものである。(Means for Solving the Problems) The present inventors have arrived at the method of the present invention as a result of intensive studies in consideration of the above problems.
−即ち本発明は、2−セリンを酵素反応により、硫化水
素、アルカリ金属水硫化物またはアルカリ金属硫化物と
反応させて得られるl−システィンを含む反応水溶液中
のl−システィンを酸化してl−シスチンを得るに際し
、ジメチルスルホキシドの存在下で酵素反応を行うこと
により、同時に反応系中においては酸化反応も行われる
ので、生成したシスティンを逐次シスチンに変換させな
がら反応を行うことを特徴とするl−セリンより!−シ
スチンの製造方法である。- That is, the present invention provides for oxidizing l-cysteine in a reaction aqueous solution containing l-cysteine obtained by reacting 2-serine with hydrogen sulfide, an alkali metal hydrosulfide, or an alkali metal sulfide through an enzymatic reaction. - When obtaining cystine, an oxidation reaction is also carried out in the reaction system by carrying out an enzymatic reaction in the presence of dimethyl sulfoxide, so the reaction is carried out while sequentially converting the produced cystine into cystine. From l-Serine! - A method for producing cystine.
このように本発明では、システィンの酸化剤として使用
するジメチルスルホキシド(以下DMSOと略す)を、
l−システィン製造時の酵素反応系において使用するこ
とにより、反応工程において生成システィンを完全にシ
スチンに変換でき、またたとえシスティン反応に硫化水
素ガスを用いた場合でも、DMSOが反応系中で硫化水
素の溶解補助剤としての作用をするので、酵素反応水性
媒体中で充分な濃度を維持して実施できる。In this way, in the present invention, dimethyl sulfoxide (hereinafter abbreviated as DMSO) used as an oxidizing agent for cysteine is
By using it in the enzymatic reaction system during the production of l-cysteine, the produced cysteine can be completely converted to cystine in the reaction process, and even if hydrogen sulfide gas is used in the cysteine reaction, DMSO can convert hydrogen sulfide in the reaction system. Since it acts as a solubilizing agent, the enzyme reaction can be carried out while maintaining a sufficient concentration in the aqueous medium.
また系中で添加したDMSOは全く酵素反応を阻害する
ことな(、酵素反応のより生成してくる!−システィン
を逐次安定な!−シスチンに酸化して酵素反応系から析
出させるため、l−システィン製造時の酵素反応速度を
著しく速めることができることもわかった。In addition, DMSO added in the system does not inhibit the enzymatic reaction at all (it is produced during the enzymatic reaction!-cystine is sequentially oxidized to stable!-cystine and precipitated from the enzyme reaction system, so l- It was also found that the enzyme reaction rate during cysteine production could be significantly accelerated.
したがって本発明は、生成した!−システィンの副生物
への分解をも防ぐことが可能となり、!−セリンから高
収率でl−シスチンを得ることができる。Therefore, the present invention has produced! -It is now possible to prevent the decomposition of cysteine into by-products! -L-cystine can be obtained from serine in high yield.
本発明において使用する酵素は、2−セリンと硫化水素
、アルカリ金属水硫化物及びアルカリ金属硫化物との酵
素反応に用いられる酵素であれば何ら制限されず、例え
ば公知のシスティン・シンターゼやシスティンデスルフ
ヒドラーゼなどの酵素を用いてもよく、また前記した出
願人の提案のトリプトファン・シンターゼを用いて反応
させることもできる。The enzyme used in the present invention is not limited in any way as long as it is an enzyme used in the enzymatic reaction between 2-serine and hydrogen sulfide, alkali metal hydrosulfide, and alkali metal sulfide. Enzymes such as rufuhydrase may be used, and tryptophan synthase proposed by the applicant described above may also be used for the reaction.
特に本発明においては、トリプトファン・シンターゼを
用いて実施するのが効果も太き(好ましい方法であり、
トリプトファン・シンターゼの酵素生産菌としては前記
特願昭60−84545号公報に開示されているように
エシェリヒア・コリ MT−10232(F E RM
B P −19)、エシェリヒア・コリ MT−1
0242(FERM BP−20)などの微生物や、
ノイロスポラ・クラッテ(ATCC14692)などの
微生物が使用できるが、特にエシェリヒア・コリから得
られたトリプトファン・シンターゼを用いるのが有利で
ある。In particular, in the present invention, it is more effective to use tryptophan synthase (the preferred method,
As the tryptophan synthase enzyme producing bacteria, Escherichia coli MT-10232 (F E RM
B P-19), Escherichia coli MT-1
Microorganisms such as 0242 (FERM BP-20),
Although microorganisms such as Neurospora kratte (ATCC 14692) can be used, it is especially advantageous to use tryptophan synthase obtained from Escherichia coli.
酵素は必ずしも抽出された純粋なものを使う必要はなく
、上記生産菌株の培養物、培養物から遠心分離などの方
法によって採取した生菌体、あるいはその凍結菌体、凍
結乾燥菌体、あるいは超音波処理などによって得られる
菌体処理物などが利用される。The enzyme does not necessarily have to be extracted and pure; it may be a culture of the above-mentioned production strain, live cells collected from the culture by methods such as centrifugation, frozen cells, freeze-dried cells, or A treated bacterial cell product obtained by sonication or the like is used.
本発明方法においては、2−セリンの基質濃度は特に制
限はないが、通常液中濃度1〜25重世%の範囲で使用
するのがよい、また反応液中における酵素の使用量は、
酵素の使用形態により異なり特に制限はなく、基質濃度
、酵素活性などの諸条件により変更される。またトリプ
トファン・シンターゼ使用の場合は、基質の他に補酵素
であるピリドキサールI)ン酸を微量、例えば液中濃度
として0.1〜50ppmの範囲で添加することが望ま
しい。In the method of the present invention, there is no particular restriction on the substrate concentration of 2-serine, but it is usually preferable to use the concentration in the solution in the range of 1 to 25%, and the amount of enzyme used in the reaction solution is as follows:
It varies depending on the usage form of the enzyme and is not particularly limited, and may be changed depending on various conditions such as substrate concentration and enzyme activity. When tryptophan synthase is used, it is desirable to add a trace amount of pyridoxal I) as a coenzyme in addition to the substrate, for example at a concentration in the solution of 0.1 to 50 ppm.
本発明においては、酵素反応時に供給するスルフヒドリ
ル基化合物としては、NaHS、にItsなどのアルカ
リ金属水硫化物であり、また直接硫化水素ガスを反応系
中に導入してもよい、硫化水素の場合は、その使用量は
i−セリンに対して1倍モル以上がよい。In the present invention, the sulfhydryl group compound to be supplied during the enzyme reaction is an alkali metal hydrosulfide such as NaHS or Its, and hydrogen sulfide gas may be directly introduced into the reaction system. It is preferable that the amount used is at least 1 times the molar amount of i-serine.
また本発明の特徴であるDMSOの使用量は、l−セリ
ンに対して0.2〜5倍モル程度であり、さらに好まし
くは0.5〜2.0倍モルが反応系中に添加される。使
用量が0.2倍モル以下であると生成!−システィンを
全量!−シスチンに変換することが難しく、また硫化水
素を使用した場合は、その溶解度も低下する。また5倍
モル以上であると著しく酵素反応を阻害する傾向になる
。Further, the amount of DMSO used, which is a feature of the present invention, is about 0.2 to 5 times the mole of l-serine, and more preferably 0.5 to 2.0 times the mole of l-serine is added to the reaction system. . Generated when the amount used is 0.2 times the mole or less! - Full amount of cysteine! - It is difficult to convert to cystine, and its solubility also decreases when hydrogen sulfide is used. Moreover, if the amount is 5 times or more by mole, the enzyme reaction tends to be significantly inhibited.
反応温度は通常20〜60°Cの範囲であり、反応pH
は5〜10である。また反応時間は、通常2〜50時間
であり、硫化水素の場合は2〜10時間がよい。The reaction temperature is usually in the range of 20 to 60°C, and the reaction pH
is 5-10. The reaction time is usually 2 to 50 hours, preferably 2 to 10 hours in the case of hydrogen sulfide.
反応液は、時間が経過するに従って白色を呈し、これは
反応液中にl−シスチン結晶が逐次析出してきているこ
とを示す。The reaction solution turned white as time passed, indicating that l-cystine crystals were successively precipitated in the reaction solution.
反応終了後の反応液中には、未反応氾−七リン及びl−
シスチンが析出した状態で存在するが、本反応液よりシ
スチンを単離するには、例えば反応液を塩酸強酸性下で
活性炭を加え加熱処理、熱濾過に付することにより酵素
菌体を除去して、反応液のpuを再び5付近まで戻すこ
とにより、!−シスチンを晶析させ通常の固液分離によ
り純度の高いl−シスチンか取得可能となる。また、こ
のようにして得られた2−シスチンを電解還元すれば、
2−システィンを得ることが出来る。After the reaction is complete, the reaction solution contains unreacted phosphorus and l-
Cystine exists in a precipitated state, but in order to isolate cystine from this reaction solution, enzyme cells are removed, for example, by adding activated carbon to the reaction solution under strong acidity of hydrochloric acid, heat-treating it, and subjecting it to hot filtration. By returning the pu of the reaction solution to around 5 again,! - Highly pure l-cystine can be obtained by crystallizing cystine and performing normal solid-liquid separation. Moreover, if the 2-cystine obtained in this way is electrolytically reduced,
2-cysteine can be obtained.
以下実施例によって本発明の詳細な説明するが、実施例
中のシスチンの分析方法は公知のガイトンデ(Ga i
tonde )の方法によりシスティン換算で算出し
た。The present invention will be explained in detail with reference to Examples below, and the cystine analysis method used in the Examples is based on the well-known Gaitonde method.
It was calculated in terms of cysteine by the method of Tonde.
すなわち、1 、000〜2,000倍に希釈した被検
液に5NMの1.4−ジチオトレイトール(還元側)約
同屡加えてさらに2NのNaOHによりpH8,0〜8
.5とし、室温にて1時間放置して含有するシスチンを
すべてシスティンに還元し、酸性ニンヒドリン試薬を用
いて発色させ、吸光度計にて560n*の吸光度を測定
する。That is, to the test solution diluted 1,000 to 2,000 times, approximately the same amount of 5 NM 1,4-dithiothreitol (on the reducing side) was added, and then the pH was adjusted to 8.0 to 8 with 2 N NaOH.
.. 5, all cystine contained is reduced to cysteine by standing at room temperature for 1 hour, color is developed using an acidic ninhydrin reagent, and absorbance at 560n* is measured using an absorbance meter.
一方、既知の濃度の標準サンプルを作成し、560nm
の吸光度の検量線を作成しておき、本検量線をもとに被
検液中のシスティン濃度を算出した。On the other hand, prepare a standard sample with a known concentration, and
A calibration curve of absorbance was prepared in advance, and the concentration of cysteine in the test liquid was calculated based on this calibration curve.
実施例1
撹拌機及び吹き込み管、排気管つきの200 d容セパ
ラブルフラスコに2−セリンlOgを、DMSO5,6
g、ピリドキサールリン酸25idを加え、イオン交換
水にて全容を100 adとする。 10%NaOH液
にて反応液のpHを8.5として反応液を35℃に一定
に保ちトリプロファン・シンターゼ含有菌体(エシェリ
ヒア・コリ MT−10242,FERM BP−2
0)を乾燥菌体換算で2.0g装入する。Example 1 In a 200 d separable flask equipped with a stirrer, blowing tube, and exhaust tube, 10 g of 2-serine was added to DMSO5,6
g, pyridoxal phosphate 25id were added, and the total volume was made up to 100 ad with ion-exchanged water. Adjust the pH of the reaction solution to 8.5 with 10% NaOH solution and keep the reaction solution constant at 35°C.
Charge 2.0g of 0) in terms of dry bacterial cells.
硫化水素ガスをボンベより約14d/分の速度で吹き込
み始め、約4時間で吹き込みを終了する。Blow-in of hydrogen sulfide gas from a cylinder was started at a rate of about 14 d/min, and the blowing was completed in about 4 hours.
(硫化水素の使用量は、対β−セリン約1.5倍モルで
ある。)その間、吹き込みを開始したら反応系内は徐々
に白色となり!−シスチンが析出した。(The amount of hydrogen sulfide used is approximately 1.5 times the mole of β-serine.) Meanwhile, when the blowing was started, the inside of the reaction system gradually turned white! -Cystine was precipitated.
反応終了後の反応液をなるべく均一にサンプリングし、
2N塩酸に熔解後遠心分離により除菌しで!−シスチン
をl−システィン換算で分析すると、9.3%、すなわ
ち!−セリンのl−シスチン転換率は約81%であった
。After the reaction is complete, sample the reaction solution as uniformly as possible.
Dissolve in 2N hydrochloric acid and sterilize by centrifugation! - When cystine is analyzed in terms of l-cystine, it is 9.3%, that is! - The conversion rate of serine to l-cystine was about 81%.
次に反応液に35%塩酸約25dを加えて、反応液のp
Hを0.5とし、活性炭1.0gを装入して、95°C
で約1時間加熱処理を付した。加熱処理後、直ちに熱濾
過を行い除菌をした。Next, add about 25 d of 35% hydrochloric acid to the reaction solution to
Set H to 0.5, charge 1.0 g of activated carbon, and heat at 95°C.
Heat treatment was applied for about 1 hour. Immediately after the heat treatment, hot filtration was performed to eliminate bacteria.
除菌後の黄透色の液を40%NaOH約5dを加えてp
H5とし、冷却によりl−シスチンの結晶を析出させた
。After sterilization, add about 5 d of 40% NaOH to the transparent yellow liquid.
H5, and l-cystine crystals were precipitated by cooling.
析出したl−シスチンの結晶をヌッチェで濾過し、イオ
ン交換水20Idで洗浄後、乾燥して白色のl−シスチ
ン結晶8.2gを得た。The precipitated l-cystine crystals were filtered through a Nutsche filter, washed with 20Id of ion-exchanged water, and then dried to obtain 8.2 g of white l-cystine crystals.
(仕込l−セリンに対して72モル%の収率)本結晶の
〔α) ”=−218,7″′、純度99.1%、アッ
シュ分0.2%と良好であった。(Yield of 72 mol % based on the charged l-serine) This crystal had good [α)'' = -218.7'', purity of 99.1%, and ash content of 0.2%.
実施例2
撹拌機つきの200 ml容セパラブルフラスコに2−
七リン10g、、DMSO5,6g、ピリドキサールリ
ン酸25■、水硫化ソーダ9.5g(試薬70%純分)
を加え、イオン交換水にて全容を200gとする。10
%NaOHにて反応液のρ)を8.0として、反応液を
35°Cに一定に保ち、実施例1に用いたトリプトファ
ンシンターゼ含有菌体を乾燥菌体換算で2.0g装入し
、反応中のpHを4モル/lリン酸により8.0に維持
する。Example 2 In a 200 ml separable flask with a stirrer, 2-
10 g of phosphorus, 5.6 g of DMSO, 25 g of pyridoxal phosphoric acid, 9.5 g of sodium hydrogen sulfide (70% pure reagent)
Add and make the total volume to 200g with ion-exchanged water. 10
% NaOH of the reaction solution was adjusted to 8.0, the reaction solution was maintained at a constant temperature of 35°C, and 2.0 g of the tryptophan synthase-containing microbial cells used in Example 1 was charged in terms of dry microbial cells. The pH during the reaction is maintained at 8.0 with 4 mol/l phosphoric acid.
反応は、pH8,0/35°Cにて約16時間行ったが
、反応開始後2時間目付近より反応系内にシスチンが析
出して白濁し始めた。The reaction was carried out at pH 8 and 0/35°C for about 16 hours, but around 2 hours after the start of the reaction, cystine precipitated in the reaction system and it started to become cloudy.
反応終了後の反応液をなるべく均一にサンプリングし、
2N塩酸に溶解後遠心分離により除菌して2−シスチン
を!−システィン換算で分析すると、9.1%すなわち
!−セリンの!−シスチンへの転換率は約79%であっ
た。After the reaction is complete, sample the reaction solution as uniformly as possible.
After dissolving in 2N hydrochloric acid, sterilize by centrifugation to obtain 2-cystine! -When analyzed in terms of cysteine, it is 9.1%! -Serin's! - Conversion rate to cystine was approximately 79%.
以下実施例1と同様にして処理をして、t−シスチンの
結晶7.6gを得た。(仕込のl−セリンに対して66
.7モル%の収率)
本結晶の〔α) ”=−220°、純度99.3%、ア
ク
ッシュ分0.1%と良好であった。Thereafter, treatment was carried out in the same manner as in Example 1 to obtain 7.6 g of t-cystine crystals. (66 for l-serine in the preparation)
.. (Yield: 7 mol %) This crystal had good [α) ”=−220°, purity of 99.3%, and acche content of 0.1%.
実施例3
撹拌機つきんの200 d容セパラブルフラスコに!−
セリン10g、DMSO5,6g、ピリドキサールリン
酸25d、硫化ソーダ9.3g(試薬純度96%以上)
を加え、イオン交換水にて全容を200gとする。Example 3 A 200 d separable flask with a stirrer! −
10g of serine, 5.6g of DMSO, 25d of pyridoxal phosphate, 9.3g of sodium sulfide (reagent purity 96% or more)
Add and make the total volume to 200g with ion-exchanged water.
10%HClにて反応のpoを8.0として反応液を3
5℃に一定に保ち、実施例1の用いたトリプトファン・
シンターゼ含有菌体を乾燥菌体換算で2.0g装入し、
反応中のpHを10%HCffiにより8.0に維持す
る。The reaction solution was diluted with 10% HCl to adjust the reaction po to 8.0.
The tryptophan used in Example 1 was kept at a constant temperature of 5°C.
Charge 2.0g of synthase-containing bacterial cells in terms of dry bacterial cells,
The pH during the reaction is maintained at 8.0 with 10% HCffi.
反応はpt18.0/35℃にて約16時間行ったが、
反応開始後2時間目付近より反応系内にシスチンが析出
して白濁し始めた。The reaction was carried out at pt18.0/35°C for about 16 hours,
Around 2 hours after the start of the reaction, cystine precipitated in the reaction system and the mixture began to become cloudy.
反応終了後の反応液をなるべく均一にサンプリングし、
2N塩酸に溶解後遠心分離により除菌してl−シスチン
を!−システィン換算で分析すると8.7%すなわちl
−セリンのl−シスチンへの転換率は約74%であった
。After the reaction is complete, sample the reaction solution as uniformly as possible.
After dissolving in 2N hydrochloric acid, sterilize by centrifugation to obtain l-cystine! -8.7% or l when analyzed in terms of cysteine
- The conversion rate of serine to l-cystine was about 74%.
以下、実施例1と同様にして処理して、!−シスチンの
結晶7.4gをえた。(仕込のl−セリンに対して64
.9モル%の収率)
本結晶の〔α〕?−−221°、純度98.9%、アッ
シュ分0.3%と良好であった。Hereafter, the process is carried out in the same manner as in Example 1. - Obtained 7.4 g of cystine crystals. (64 for l-serine in the preparation)
.. 9 mol% yield) [α] of this crystal? --221°, purity 98.9%, and ash content 0.3%.
実施例4
撹拌機つきの200 d容セパラブルフッラスコに2−
セリンlOg、DMSO5,6g、及びイオン交換水に
て全容を50gとする。Example 4 In a 200 d capacity separable flask with a stirrer, 2-
The total volume was made up to 50 g with 10 g of serine, 5.6 g of DMSO, and ion exchange water.
システィンデスルヒドラーゼ含有酵素液(バチルス・ズ
ブチリス A T CC6051を培養後集菌し、バッ
ファー中で超音波により菌体破砕したもの)を加え、N
aOH液にてptts、sとし、反応液全容を100g
とする。Cysteine desulfhydrase-containing enzyme solution (Bacillus subtilis AT CC6051 was collected after culturing and disrupted by ultrasonic waves in a buffer) was added, and N
Make ptts and s with aOH solution, and bring the total volume of the reaction solution to 100g.
shall be.
硫化水素ガスをボンベより約14rI11ノ分の速度で
吹き込み始め、約4時間で吹き込みを終了した。Hydrogen sulfide gas was started to be blown in from the cylinder at a rate of about 14rI11 minutes, and the blowing was completed in about 4 hours.
(硫化水素の使用量は、対!−セリン約1.5倍モル)
その間、吹き込みを開始したら反応系内は徐々に白色と
なりl−シスチンが析出した。(The amount of hydrogen sulfide used is approximately 1.5 times the mole of serine)
Meanwhile, when the blowing was started, the inside of the reaction system gradually turned white and l-cystine was precipitated.
反応終了後の反応液をなるべく均一にサンプリングし、
2N塩酸に溶解後遠心分離のにより除菌して!−シスチ
ンを2−システィン換算で分析すると、5.8%、すな
わちl−セリンのl−シスチンへの転換率は約53%で
あった。また反応系内のシスティンのみの濃度を測定す
ると0.1%以下であった。After the reaction is complete, sample the reaction solution as uniformly as possible.
Sterilize by dissolving in 2N hydrochloric acid and centrifuging! - Cystine was analyzed in terms of 2-cystine and was found to be 5.8%, that is, the conversion rate of l-serine to l-cystine was approximately 53%. Furthermore, when the concentration of cysteine alone in the reaction system was measured, it was found to be 0.1% or less.
Claims (1)
リ金属硫化物、またはアルカリ金属水硫化物と反応させ
て得られるl−システィンを含む反応水溶液中のl−シ
スティンを、酸化してl−シスチンを得るに際し、ジメ
チルスルホキシドの存在下で酵素反応を行い、生成した
システィンを、逐次シスチンに変換させながら反応を行
うことを特徴とするl−セリンよりl−シスチンの製造
方法。 2)、l−セリンの酵素反応をトリプトファンシンター
ゼの存在下で行う特許請求の範囲第1項記載の方法。[Claims] 1) l-cysteine in a reaction aqueous solution containing l-cysteine obtained by reacting l-serine with hydrogen sulfide, an alkali metal sulfide, or an alkali metal hydrosulfide through an enzymatic reaction. , Production of l-cystine from l-serine, characterized by carrying out an enzymatic reaction in the presence of dimethyl sulfoxide when oxidizing to obtain l-cystine, and carrying out the reaction while sequentially converting the produced cystine to cystine. Method. 2) The method according to claim 1, wherein the enzymatic reaction of l-serine is carried out in the presence of tryptophan synthase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9190287A JPS63258850A (en) | 1987-04-16 | 1987-04-16 | Production of l-cystine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9190287A JPS63258850A (en) | 1987-04-16 | 1987-04-16 | Production of l-cystine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63258850A true JPS63258850A (en) | 1988-10-26 |
Family
ID=14039503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9190287A Pending JPS63258850A (en) | 1987-04-16 | 1987-04-16 | Production of l-cystine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63258850A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007246481A (en) * | 2006-03-17 | 2007-09-27 | Japan Science & Technology Agency | Synthetic methods of serine, cystine, and alanine regio- and stereoselectively labeled with stable isotope |
-
1987
- 1987-04-16 JP JP9190287A patent/JPS63258850A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007246481A (en) * | 2006-03-17 | 2007-09-27 | Japan Science & Technology Agency | Synthetic methods of serine, cystine, and alanine regio- and stereoselectively labeled with stable isotope |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL195784B1 (en) | Microorganisms and fermentation processes used in production of l-cysteine, l-cystine, n-acetylserine or thiazolydine derivatives | |
Daffe et al. | Enantiomeric enrichment in the hydrolysis of oxazolones catalyzed by cyclodextrins or proteolytic enzymes | |
US4733010A (en) | Method of separating monohydrate of L-cysteine hydrochloride | |
EP0272365B1 (en) | Method of producing l-cystine | |
Chocat et al. | Synthesis of selenocystine and selenohomocystine with O-acetylhomoserine sulfhydrylase | |
JPS63258850A (en) | Production of l-cystine | |
JPH0527389B2 (en) | ||
US4769491A (en) | Method for production of cystine from cysteine | |
JPS62253390A (en) | Production of l-cystine | |
JPS637790A (en) | Production of l-cysteine by enzyme | |
JPH0471906B2 (en) | ||
JPS63258851A (en) | Production of cystine from cysteine | |
KR900008250B1 (en) | Process for preparing cystine from cystein | |
JPS58187198A (en) | Preparation of s-carboxymethyl-l-cysteine | |
CA1291159C (en) | Method for production of cystine from cysteine | |
Itahara | Oxidation of thymines with hydrogen peroxide in hydrochloric acid | |
JPS63258849A (en) | Production of cystine from cysteine | |
JP2716477B2 (en) | Method for producing S-carboxymethyl-L-cysteine | |
KR970004014B1 (en) | Enhanced preparing method of l-tryptophan by tryptophanase using glycerol | |
JPH0254077B2 (en) | ||
JPH0611232B2 (en) | Method for producing L-sulfur-containing amino acid | |
JP3345551B2 (en) | Method for producing S-phenyl-L-cysteine | |
JPH0566119B2 (en) | ||
JPH0614868B2 (en) | Method for producing L-sulfur-containing amino acid | |
JPH0630572B2 (en) | L-phenylalanine dehydrogenase |